4D Molecular Therapeutics closes $129.1M public offering of 8.625M shares at $16/share

4D Molecular Therapeutics, Inc.

Sold 7.5M firm shares plus 1.125M overallotment shares at $16.00 per share, netting ~$129.1M.
Underwriters include Goldman Sachs, BofA Securities, and Evercore; lock-up restrictions until July 3, 2023.
Offering closed on May 9, 2023; proceeds for general corporate purposes per shelf registration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.